What does clinical diagnostics — restructuring charges mean?

The immediate costs incurred from reorganizing or downsizing the Clinical Diagnostics business.

How do you interpret clinical diagnostics — restructuring charges?

High charges indicate aggressive cost-cutting or operational transformation, which may temporarily depress margins but improve future profitability.

How does clinical diagnostics — restructuring charges compare across companies?

Commonly reported by mature companies seeking to optimize cost structures in response to market shifts.

Bio-Rad Laboratories, Inc. BIO.B Clinical Diagnostics — Restructuring Charges

Discontinued — last reported Q4 '25

Similar metrics at other companies

LHLab Corp Diagnostics — Restructuring Charges

$2M+17.6%

TEC

TECHDiagnostics And Genomics — Restructuring Charges

$14K—

LHLabCorp Diagnostics — Restructuring Charges

$8.35M+7.4%

LHLab Corp Diagnostics — Net Restructuring Charges

$3.3M+106%

TEC

TECHDiagnostics And Spatial Biology — Restructuring Charges

$27K—

TEC

TECHDiagnostics And Genomics — Restructuring Costs Net Of Adjustments

$137K-60.8%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s clinical diagnostics — restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s clinical diagnostics — restructuring charges?: Bio-Rad Laboratories, Inc. (BIO.B) reported clinical diagnostics — restructuring charges of $2.9M in Q4 2025.
What does clinical diagnostics — restructuring charges mean?: The immediate costs incurred from reorganizing or downsizing the Clinical Diagnostics business.
How do you interpret clinical diagnostics — restructuring charges?: High charges indicate aggressive cost-cutting or operational transformation, which may temporarily depress margins but improve future profitability.
How does clinical diagnostics — restructuring charges compare across companies?: Commonly reported by mature companies seeking to optimize cost structures in response to market shifts.